Nima Mousavi Darzikolaee

Nima Mousavi Darzikolaee

Auto-generated profile, based on publicly available information

Nima Mousavi Darzikolaee

Department of Radiation Oncology, Imam Khomeini Hospital Complex, School of Medicine Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2019 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
MAMahdi Aghili
Mahdi Aghili
MZMahkameh Zare
Mahkameh Zare
NMNima Mousavi
Nima Mousavi
RGReza Ghalehtaki
Reza Ghalehtaki
SSSarvazad Sotoudeh
Sarvazad Sotoudeh
EEEbrahim Esmati
Ebrahim Esmati

2 March 2018 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
EEEbrahim Esmati
Ebrahim Esmati
ASAfsaneh Maddah Safaei
Afsaneh Maddah Safaei
RGReza Ghalehtaki
Reza Ghalehtaki
NMNima Mousavi
Nima Mousavi
ESEhsan Saraee
Ehsan Saraee
MLMarzieh Lashkari
Marzieh Lashkari

7 May 2022 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
KKKasra Kolahdouzan
Kasra Kolahdouzan
MCMohammadreza Chavoshi
Mohammadreza Chavoshi
RBReyhaneh Bayani
Reyhaneh Bayani
NDNima Mousavi Darzikolaee
Nima Mousavi Darzikolaee

14 April 2022 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
MAMahdi Aghili
Mahdi Aghili
NDNima Mousavi Darzikolaee
Nima Mousavi Darzikolaee
MBMohammad Babaei
Mohammad Babaei
RGReza Ghalehtaki
Reza Ghalehtaki
FFFarshid Farhan
Farshid Farhan
AAArdavan Amiri
Ardavan Amiri

5 April 2024 in Cancer Reports
Verified
Journal Article
Open access
MGMaryam Garousi
Maryam Garousi
NDNima Mousavi Darzikolaee
Nima Mousavi Darzikolaee
AFAli Faridfar
Ali Faridfar
SJSeyed Mohammadreza Javadi
Seyed Mohammadreza Javadi
ESEsmaeil Samizadeh
Esmaeil Samizadeh
RBReyhaneh Bayani
Reyhaneh Bayani
Background: Prostate cancer is the second most common cancer in men. Central nervous system (CNS) involvement in prostate cancer which manifests as cerebral, leptomeningeal, or dural involvement is uncommon and occurs late in the course of disease.Case: A 60‐year‐old patient with castration resistant prostate cancer (CRPC) presented with headache and fatigue. Evaluation revealed bone marrow and leptomeningeal involvement. The patient treated by whole brain radiotherapy, leuprolide, weekly docetaxel and daily 1000 mg abiraterone. Complete blood count (CBC) and CNS symptoms improved and the patient is alive after 11 months with excellent performance status.Conclusion: Leptomeningeal involvement in prostate cancer is rare and is associated with a poor prognosis but the possibility of such event should be considered in patients with new onset progressive CNS symptoms. New treatment strategies such as combination of docetaxel and abiraterone added to androgen deprivation therapy (triplet therapy) might improve outcome in these patients.

23 June 2024 in Clinical Case Reports
Verified
Journal Article
Open access
RBReyhaneh Bayani
Reyhaneh Bayani
EHElyas Hasanzadeh
Elyas Hasanzadeh
EJEtrat Javadirad
Etrat Javadirad
AAAli Reza Azarpeikan
Ali Reza Azarpeikan
MBMohammad Babaei
Mohammad Babaei
NDNima Mousavi Darzikolaee
Nima Mousavi Darzikolaee
Key Clinical Message: Adenoid cystic carcinoma (ACC) is an uncommon malignancy of head and neck. Although the cornerstone of treatment is surgery, concurrent chemoradiotherapy (CRT) might be used as an effective treatment for unresectable tumors. Herein we report a case of massive ACC of base of tongue with durable complete response to definitive CRT. Adenoid cystic carcinoma (ACC) is a rare tumor accounting for 1% of all head and neck cancers. The best treatment option is complete surgical resection with or without adjuvant radiotherapy. When surgical resection is not feasible, definitive radiotherapy with or without concurrent chemotherapy can be considered. Herein we report a non‐smoker 72‐year‐old woman presented with throat discomfort and sensation of a lump. Evaluation revealed an unresectable adenoid cystic carcinoma of the base of tongue in whom complete clinical response was achieved after definitive concurrent chemoradiation. Although the cornerstone of treatment is complete surgical resection, this case report indicates that concurrent chemoradiotherapy might result in complete clinical response and could be used as a definitive treatment in selected ACC tumors.